Search Results

To Listen to Audio click the Play Button [beneath each segment] which varies based on the browser you are using.

October 7, 2020

Title: Failure to Warn
Topic: Prescription Drug Safety

Discussed by Richard Meadow
with Lanier Law Firm (www.LanierLawFirm.com)

Disclaimer: Please do not construe any statement made during this interview as legal advice. Always consult your attorney for advice on this and other legal issues.

Have you or a loved one taken the prescription drug Elmiron? This drug, used for bladder pain, has caused vision loss in some people.

Rick Meadow offers more information about this harmful prescription drug today. Click here  to contact the Lanier Law Firm for questions about this topic.

Questions/Issues Discussed:

Do prescription drugs often have unknown side-effects years after initial testing?

Do prescription drugs often have unintended consequences that are discovered during the trial/testing phase prior to FDA approval?

Does the FDA do testing on prescription drugs? Or does the drug-maker do the testing?

Why are pharmaceutical companies required to list known side-effects? Is this known as “informed consent”?

After a prescription drug has been on the market for years, can unknown side-effects become apparent?

Are drug manufacturers required to tell the public as they become aware of new side-effects of the prescription drugs?

Has recent research found that the prescription drug Elmiron can damage people’s eyes and even cause vision loss?

Have product liability lawsuits been filed against the maker of Elmiron for failure to warn?

More from this Guest      More on this Topic      More from this Organization

September 20, 2019

Title: Prescription Drug Safety and Costs
Topic: Prescription Drug Safety

Discussed by Peter Pitts
with The Center for Medicine in the Public Interest (www.CMPI.org)

Part 1 of 3

In his new book, “Common Sense Health Policy for Common Sense Americans (and Presidential Candidates)”, Peter Pitts pleads for sanity and stresses it’s time to put away unworkable soundbite solutions.

Questions/Issues Discussed:

Do polls indicate that voters have serious concerns about the future of medical insurance and medical care in America?

Is there a difference between having insurance and receiving timely, quality, affordable care?

Will a “Medicare For All” program work in America?

More from this Guest      More on this Topic      More from this Organization

Title: Part 2 of 3 - Prescription Drug Safety and Costs
Topic: Prescription Drug Safety

Discussed by Peter Pitts
with The Center for Medicine in the Public Interest (www.CMPI.org)

Questions/Issues Discussed:

What are the three ideas behind Nancy Pelosi’s HR3?

Who pays less for prescription drugs: Americans or Canadians?

What is the International Pricing Index?

The majority of Research and Development (R&D) happens right here in America. Is the cost for R&D passed along to the people buying the prescriptions?

More from this Guest      More on this Topic      More from this Organization

Title: Part 3 of 3 - Prescription Drug Safety and Costs
Topic: Prescription Drug Safety

Discussed by Peter Pitts
with The Center for Medicine in the Public Interest (www.CMPI.org)

Questions/Issues Discussed:

Should the US government directly negotiate the price for a prescription drug?

Should rebates be used to off-set price hikes?

Should the US just re-import prescription drugs from countries like Canada? Where did these drugs “really” come from? HINT: Probably China!!!

How do we succeed in advancing the quality and accessibility of medical care in the US?

Click here for more information about Peter Pitt’s new book.

More from this Guest      More on this Topic      More from this Organization

April 18, 2019

Title: BREAKING NEWS? Contaminated Generic Drugs
Topic: Prescription Drug Safety

Discussed by Peter Pitts
with The Center for Medicine in the Public Interest (www.CMPI.org)

Generic drugs represent 90% of the volume of medicine consumed by Americans. Medications approved by the FDA rest upon three pillars: safety, efficacy and quality. Up until recently, quality has been a silent partner, but that’s no longer acceptable.

Peter Pitts says this of the crisis: “Quality can be stipulated, but it cannot be assumed.” Peter is the former FDA Associate Commissioner and current President and Co-Founder of The Center for Medicine in the Public Interest.

Questions/Issues Discussed:

Are all generic drugs “identical” to its innovator reference product?

When a generic drug is not “the same as” or “identical to” its brand cousin, is the generic drug then a “bioequivalent”?

Why have 282 warning letters have been sent to pharmaceutical companies related to manufacturing problems since 2015? Peter discusses the contaminations that have been discovered…

Click here  for more on this and other health related issues.

More from this Guest      More on this Topic      More from this Organization

April 20, 2017

Title: Imported Prescription Drugs: Good or Bad?
Topic: Prescription Drug Safety

Discussed by Peter Pitts
with The Center for Medicine in the Public Interest (www.CMPI.org)

Part 1 of 2

Peter Pitts is the former FDA Associate Commissioner and current President and Co-Founder of The Center for Medicine in the Public Interest . He is urging President Donald Trump to resist all drug importation from Canada, as well as other countries. Listen in as he discusses this highly important issue that all Americans should pay attention to.

Questions/Issues Discussed:

Would Importing drugs also place price controls imposed by foreign governments?

Are the majority of prescription drugs cheaper in America than other countries?

What happens after an American pharmaceutical company manufactures a drug and then sells it to a foreign country? Does the price stay the same or does it spike?

Do consumers in America pay for the research and development for new drugs?

Do pharmaceutical companies perform research and development in America or in foreign countries?

More from this Guest      More on this Topic      More from this Organization

Title: Part 2 of 2 - Imported Prescription Drugs: Good or Bad?
Topic: Prescription Drug Safety

Discussed by Peter Pitts
with The Center for Medicine in the Public Interest (www.CMPI.org)

“Trump has presented himself as the great negotiator,” Pitts said. “He knows how to get deals. Let’s take him at his word and say, ‘Get out there and tell our allies that they have to carry their fair share of drug development costs.’ That simply can’t fall on American patients.”

Questions/Issues Discussed:

Are the prescription drugs imported into the US as safe as those manufactured here?

Is it a good idea to buy prescription drugs online from a foreign country?

Are generic drugs exactly the same as the patented drug?

To save Americans money, should President Trump begin negotiations immediately?

Click here for more information on this issue.

More from this Guest      More on this Topic      More from this Organization